Shanghai Biochip Corporation (SBC) is a prominent player in the biotechnology and healthcare industries. Founded in August 2001, the company has established a strong foothold in its sector. It is supported by influential shareholders, including Shanghai Technology Venture Capital (Group) Co., Ltd., Shanghai Zhangjiang (Group) Co., Ltd., the Shanghai Institute of Life Sciences, Chinese Academy of Sciences, the Shanghai Institute of Microsystems and Information Technology Research Institute, Fudan University, Shanghai Jiaotong University, Shanghai Yidian (Group) Co., Ltd., Shanghai Jiaotong University School of Medicine, Ruijin Hospital, and Shanghai Boxing Gene Chip Co., Ltd. The company's extensive network of backers, comprising various Shanghai-based technology and academic institutions, underscores its credibility and potential for growth. Based in China, SBC has yet to disclose its latest investment details. Overall, Shanghai Biochip Corporation presents a compelling investment opportunity within the dynamic realms of biotechnology and healthcare.
There is no investment information
No recent news or press coverage available for 上海生物芯片有限公司 Shanghai Biochip Corporation (SBC).